Protease-Activated Receptor 4 (PAR4): A Promising Target for Antiplatelet Therapy

Cardiovascular diseases (CVDs) are currently among the leading causes of death worldwide. Platelet aggregation is a key cellular component of arterial thrombi and major cause of CVDs. Protease-activated receptors (PARs), including PAR1, PAR2, PAR3 and PAR4, fall within a subfamily of seven-transmemb...

Descripción completa

Detalles Bibliográficos
Autores principales: Rwibasira Rudinga, Gamariel, Khan, Ghulam Jilany, Kong, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5855795/
https://www.ncbi.nlm.nih.gov/pubmed/29443899
http://dx.doi.org/10.3390/ijms19020573

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5855795/
https://www.ncbi.nlm.nih.gov/pubmed/29443899
http://dx.doi.org/10.3390/ijms19020573

Ejemplares similares